These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6362846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adjuvant Corynebacterium parvum immunotherapy for squamous cell epitheliomas of the oral cavity, pharynx, and larynx.
    Neifeld JP, Terz JJ, Kaplan AM, Lawrence W.
    J Surg Oncol; 1985 Feb; 28(2):137-45. PubMed ID: 3881630
    [Abstract] [Full Text] [Related]

  • 3. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
    [Abstract] [Full Text] [Related]

  • 4. Intrapleural and intravenous Corynebacterium parvum in patients with resected stage I and II non-small cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.
    Ludwig Lung Cancer Study Group.
    Cancer Immunol Immunother; 1986 Jun; 23(1):1-4. PubMed ID: 2876772
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant intralesional and systemic Corynebacterium parvum immunotherapy for surgically treated head and neck cancer.
    Beatty JD, Terz JJ, Brown PW, Lawrence W, Schuller GB, Kaplan AM.
    Surg Forum; 1978 Jun; 29():155-7. PubMed ID: 401122
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
    Karrer K, Rella W, Goldin A.
    Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma.
    Lipton A, Harvey HA, Balch CM, Antle CE, Heckard R, Bartolucci AA.
    J Clin Oncol; 1991 Jul; 9(7):1151-6. PubMed ID: 2045856
    [Abstract] [Full Text] [Related]

  • 10. Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study.
    DiSaia PJ, Bundy BN, Curry SL, Schlaerth J, Thigpen JT.
    Gynecol Oncol; 1987 Mar; 26(3):386-97. PubMed ID: 3549476
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the worth of corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer. Eight-year results from the National Surgical Adjuvant Breast and Bowel Project B-10.
    Fisher B, Brown A, Wolmark N, Fisher ER, Redmond C, Wickerham DL, Margolese R, Dimitrov N, Pilch Y, Glass A.
    Cancer; 1990 Jul 15; 66(2):220-7. PubMed ID: 2196108
    [Abstract] [Full Text] [Related]

  • 13. Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
    Issell BF, Valdivieso M, Hersh EM, Richman S, Gutterman JU, Bodey GP.
    Cancer Treat Rep; 1978 Jul 15; 62(7):1059-63. PubMed ID: 356968
    [Abstract] [Full Text] [Related]

  • 14. [The use of Corynebacterium parvum in pleurodesis].
    Helin T, Haahtela T.
    Duodecim; 1988 Jul 15; 104(4):262-5. PubMed ID: 3168834
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
    Chahinian AP, Goldberg J, Holland JF, Reisman A, Jaffrey IS, Mandel EM.
    Cancer Treat Rep; 1982 Jun 15; 66(6):1291-7. PubMed ID: 6282455
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.
    Hollinshead AC, Stewart TH.
    Yale J Biol Med; 1981 Jun 15; 54(5):367-79. PubMed ID: 7039148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
    Bjornsson S, Takita H, Kuberka N, Preisler H, Catane H, Higby D, Henderson E.
    Cancer Treat Rep; 1978 Apr 15; 62(4):505-10. PubMed ID: 350388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.